Annals of Surgical Oncology, Vol 5, Issue 8 681-688, Copyright © 1998 by Society of Surgical Oncology

ARTICLES

Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]

M. Bouvet, R. J. Bold, J. Lee, D. B. Evans, J. L. Abbruzzese, P. J. Chiao, D. J. McConkey, J. Chandra, S. Chada, B. Fang and J. A. Roth
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

BACKGROUND: The p53 tumor suppressor gene is mutated in up to 70% of pancreatic adenocarcinomas. We determined the effect of reintroduction of the wild-type p53 gene on proliferation and apoptosis in human pancreatic cancer cells using an adenoviral vector containing the wild-type p53 tumor suppressor gene. METHODS: Transduction efficiencies of six p53-mutant pancreatic cancer cell lines (AsPC-1, BxPC-3, Capan-1, CFPAC-1, MIA PaCa-2, and PANC-1) were determined using the reporter gene construct Ad5/CMV/beta-gal. Cell proliferation was monitored using a 3H-thymidine incorporation assay, Western blot analysis for p53 expression was performed, and DNA laddering and fluorescence-activated cell sorter analysis were used to assess apoptosis. p53 gene therapy was tested in vivo in a subcutaneous tumor model. RESULTS: The cell lines varied in transduction efficiency. The MIA PaCa-2 cells had the highest transduction efficiency, with 65% of pancreatic tumor cells staining positive for beta-galactosidase (beta-gal) at a multiplicity of infection (MOI) of 50. At the same MOI, only 15% of the CFPAC-1 cells expressed the beta-gal gene. Adenovirus-mediated p53 gene transfer suppressed growth of all human pancreatic cancer cell lines in a dose-dependent manner. Western blot analysis confirmed the presence of the p53 protein product at 48 hours after infection. DNA ladders demonstrated increased chromatin degradation, and fluorescence-activated cell sorter analysis demonstrated a four-fold increase in apoptotic cells at 48 and 72 hours following infection with Ad5/CMV/p53 in the MIA PaCa-2 and PANC-1 cells. Suppression of tumor growth mediated by induction of apoptosis was observed in vivo in an established nude mouse subcutaneous tumor model following intratumoral injections of Ad5/CMV/p53. CONCLUSIONS: Introduction of the wild-type p53 gene using an adenoviral vector in pancreatic cancer with p53 mutations induces apoptosis and inhibits cell growth. These data provide preliminary support for adenoviral mediated p53 tumor suppressor gene therapy of human pancreatic cancer.

This article has been cited by other articles:

				D. Menendez, A. Inga, and M. A. Resnick The Biological Impact of the Human Master Regulator p53 Can Be Altered by Mutations That Change the Spectrum and Expression of Its Target Genes. Mol. Cell. Biol., March 1, 2006; 26(6): 2297 - 2308. [Abstract] [Full Text] [PDF]

				F. Trapasso, S. Yendamuri, K. R. Dumon, R. Iuliano, R. Cesari, B. Feig, R. Seto, L. Infante, H. Ishii, A. Vecchione, et al. Restoration of receptor-type protein tyrosine phosphatase {eta} function inhibits human pancreatic carcinoma cell growth in vitro and in vivo Carcinogenesis, November 1, 2004; 25(11): 2107 - 2114. [Abstract] [Full Text] [PDF]

				D. Jacob, J. Davis, H. Zhu, L. Zhang, F. Teraishi, S. Wu, F. C. Marini III, and B. Fang Suppressing Orthotopic Pancreatic Tumor Growth with a Fiber-Modified Adenovector Expressing the TRAIL Gene from the Human Telomerase Reverse Transcriptase Promoter Clin. Cancer Res., May 15, 2004; 10(10): 3535 - 3541. [Abstract] [Full Text] [PDF]

				Y Tsunemitsu, S Kagawa, N Tokunaga, S Otani, T Umeoka, J A Roth, B Fang, N Tanaka, and T Fujiwara Molecular therapy for peritoneal dissemination of xenotransplanted human MKN-45 gastric cancer cells with adenovirus mediated Bax gene transfer Gut, April 1, 2004; 53(4): 554 - 560. [Abstract] [Full Text] [PDF]

				M. H. Katz, D. E. Spivack, S. Takimoto, B. Fang, D. W. Burton, A.R. Moossa, R. M. Hoffman, and M. Bouvet Gene Therapy of Pancreatic Cancer With Green Fluorescent Protein and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Fusion Gene Expression Driven by a Human Telomerase Reverse Transcriptase Promoter Ann. Surg. Oncol., August 1, 2003; 10(7): 762 - 772. [Abstract] [Full Text] [PDF]

				B. Peng, J. B. Fleming, T. Breslin, A. M. Grau, S. Fojioka, J. L. Abbruzzese, D. B. Evans, D. Ayers, K. Wathen, T. Wu, et al. Suppression of Tumorigenesis and Induction of p15ink4b by Smad4/DPC4 in Human Pancreatic Cancer Cells Clin. Cancer Res., November 1, 2002; 8(11): 3628 - 3638. [Abstract] [Full Text] [PDF]

				M. Bouvet, J. Wang, S. R. Nardin, R. Nassirpour, M. Yang, E. Baranov, P. Jiang, A. R. Moossa, and R. M. Hoffman Real-Time Optical Imaging of Primary Tumor Growth and Multiple Metastatic Events in a Pancreatic Cancer Orthotopic Model Cancer Res., March 1, 2002; 62(5): 1534 - 1540. [Abstract] [Full Text] [PDF]

				C. Pollmann, X. Huang, J. Mall, D. Bech-Otschir, M. Naumann, and W. Dubiel The Constitutive Photomorphogenesis 9 Signalosome Directs Vascular Endothelial Growth Factor Production in Tumor Cells Cancer Res., December 1, 2001; 61(23): 8416 - 8421. [Abstract] [Full Text] [PDF]

				K. R. Dumon, H. Ishii, A. Vecchione, F. Trapasso, G. Baldassarre, F. Chakrani, T. Druck, E. F. Rosato, N. N. Williams, R. Baffa, et al. Fragile Histidine Triad Expression Delays Tumor Development and Induces Apoptosis in Human Pancreatic Cancer Cancer Res., June 1, 2001; 61(12): 4827 - 4836. [Abstract] [Full Text] [PDF]

				T. Plath, K. Detjen, M. Welzel, Z. von Marschall, D. Murphy, M. Schirner, B. Wiedenmann, and S. Rosewicz A Novel Function for the Tumor Suppressor p16INK4a: Induction of Anoikis via Upregulation of the {alpha}5{beta}1 Fibronectin Receptor J. Cell Biol., September 18, 2000; 150(6): 1467 - 1478. [Abstract] [Full Text] [PDF]

				T. A. Steele Recent Developments in the Virus Therapy of Cancer Experimental Biology and Medicine, February 1, 2000; 223(2): 118 - 127. [Abstract] [Full Text]